In the case of ACECLO versus ACECLOHEAL, aceclofenac-derived branding ran into Section 13 and the publici juris problem. Registration didn’t rescue exclusivity, and the visual and market differences did the rest.
Read more about Aceclofenac Marks and the Limits of Exclusivity: The ACECLO Dispute